亚洲 · 区域市场 · CNBC-TV18
Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33%
At the operating level, the company reported EBITDA of ₹547.6 crore for the quarter. Its EBITDA margin expanded to 30.5% from 24.2% in the corresponding period last year.
在 CNBC-TV18 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.cnbctv18.com)
